Finally, qPCR showed that combined treatment induced an increase of gene expression of ifn signature markers (Fig. 4A and 7A), which are typically associated with favorable cancer prognosis and immunotherapy response [41–44]. This evidence concerns the gene IFNA1 and cancer.